Wipfli Financial Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Wipfli Financial Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$128K	Buy	+12,225	New	+$130K	0.01%	619

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wipfli Financial Advisors's RDY Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Dr. Reddy's Laboratories (RDY) in Q3 2022: 12,225 shares worth $128K. The stake represents 0.01% of the portfolio and ranks #619 among its holdings.

151 funds tracked by Wall St. Rank hold RDY as of Q3 2022.

Wipfli Financial Advisors held 12,225 shares of Dr. Reddy's Laboratories worth $128K as of Q3 2022.
Dr. Reddy's Laboratories was a new Wipfli Financial Advisors position in Q3 2022.
Dr. Reddy's Laboratories made up 0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #619 holding.
151 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.